Cargando…
Therapeutic advances in sickle cell disease in the last decade
Autores principales: | Shet, Arun S., Thein, Swee Lay |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5674537/ https://www.ncbi.nlm.nih.gov/pubmed/29067969 http://dx.doi.org/10.4103/ijmr.IJMR_1153_17 |
Ejemplares similares
-
COVID-19 and sickle cell disease
por: Menapace, Laurel A., et al.
Publicado: (2020) -
GlycA is not a useful biomarker of inflammation in sickle cell disease
por: Weisman, Julie K., et al.
Publicado: (2018) -
Post-translational modification as a response to cellular stress induced by hemoglobin oxidation in sickle cell disease
por: Strader, Michael Brad, et al.
Publicado: (2020) -
World Sickle Cell Day 2016 : A time for appraisal
por: Thein, Mya S., et al.
Publicado: (2016) -
The carrier state for sickle cell disease is not completely harmless
por: Xu, Julia Zhe, et al.
Publicado: (2019)